Apolipoprotein E4 genotype and depressive symptoms as risk factors for dementia in an older Korean population

Psychiatry Investigation

Volumn 7, Issue 2, 2010, Pages 135-140

  Kim, Jae Min ^a   Kim, Seon Young ^a   Bae, Kyung Yeol ^a   Kim, Sung Wan ^a   Shin, Il Seon ^a   Yang, Su Jin ^a   Song, Young Heon ^a   Yoon, Jin Sang ^a  

^a Chonnam National University   (South Korea)

Author keywords

Alzheimer's disease; Apolipoprotein E; Dementia; Depression; Gene association study

Indexed keywords

APOLIPOPROTEIN E4;

AGE DISTRIBUTION; AGED; ALCOHOL CONSUMPTION; ARTICLE; CARDIOVASCULAR RISK; CONTROLLED STUDY; DEMENTIA; DEPRESSION; DISABILITY; DNA POLYMORPHISM; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; GENOTYPE; GERIATRIC DEPRESSION SCALE; HUMAN; KOREA; MAJOR CLINICAL STUDY; MALE; MORBIDITY; PHYSICAL ACTIVITY; POPULATION RESEARCH; RISK FACTOR; SEX DIFFERENCE;

EID: 77954401319     PISSN: 17383684     EISSN: None     Source Type: Journal    
DOI: 10.4306/pi.2010.7.2.135     Document Type: Article

References (44)

1. Bertram L, Tanzi RE. Thirty years of Alzheimer's disease genetics: the implications of systematic meta-analyses. Nat Rev Neurosci 2008;9:768-778.
2. Pálsson S, Aevarsson O, Skoog I. Depression, cerebral atrophy, cognitive performance and incidence of dementia. Population study of 85-year- olds. Br J Psychiatry 1999;174:249-253.
3. Fuhrer R, Dufouil C, Dartigues JF; PAQUID Study. Exploring sex differences in the relationship between depressive symptoms and dementia incidence: prospective results from the PAQUID Study. J Am Geriatr Soc 2003;51:1055-1063.
4. Dal Fomo G, Palermo MT, Donohue JE, Karagiozis H, Zonderman AB, Kawas CH. Depressive symptoms, sex, and risk for Alzheimer's disease. Ann Neurol 2005;57:381-387.
5. Ganguli M, Du Y, Dodge HH, Ratcliff GG, Chang CC. Depressive symptoms and cognitive decline in late life: a prospective epidemiological study. Arch Gen Psychiatry 2006;63:153-160. (Pubitemid 43213876)
6. Brown EL, Raue P, Halpert KD, Adams S, Titler MG. Detection of depression in older adults with dementia. J Gerontol Nurs 2009;35:11-15.
7. Chen R, Hu Z, Wei L, Qin X, McCracken C, Copeland JR. Severity of depression and risk for subsequent dementia: cohort studies in China and the UK. Br J Psychiatry 2008;193:373-377.
8. Ownby RL, Crocco E, Acevedo A, John V, Loewenstein D. Depression and risk for Alzheimer disease: systematic review, meta-analysis, and metaregression analysis. Arch Gen Psychiatry 2006;63:530-538.
9. McCarron MO, Delong D, Alberts MJ. APOE genotype as a risk factor for ischemic cerebrovascular disease: a meta-analysis. Neurology 1999; 53:1308-1311. (Pubitemid 29480092)
10. Nebes RD, Vora IJ, Meltzer CC, Fukui MB, Williams RL, Kamboh MI, et al. Relationship of deep white matter hyperintensities and apolipoprotein E genotype to depressive symptoms in older adults without clinical depression. Am J Psychiatry 2001;158:878-884.
11. Alexopoulos GS, Meyers BS, Young RC, Capbell S, Silbersweig D. Charlson M. 'Vascular depression' hypothesis. Arch Gen Psychiatry 1997;54:915-922.
12. Irie F, Masaki KH, Petrovitch H, Abbott RD, Ross GW, Taaffe DR, et al. Apolipoprotein E epsilon4 allele genotype and the effect of depressive symptoms on the risk of dementia in men: the Honolulu-Asia Aging Study. Arch Gen Psychiatry 2008;65:906-912.
13. Prince M, Acosta D, Chiu H, Scazufca M, Varghese M; 10/66 Dementia Research Group. Dementia diagnosis in developing countries: a cross-cultural validation study. Lancet 2003;361:909-917.
14. Kim JM, Stewart R, Kim SW, Yang SJ, Shin IS, Kim YH, et al. Interactions between life stressors and susceptibility genes (5-HTTLPR and BDNF) on depression in Korean elders. Biol Psychiatry 2007;62:423-428. (Pubitemid 47284032)
15. Kim JM, Stewart R, Kim SW, Shin IS, Yang SJ, Shin HY, et al. Changes in folate, vitamin B12, and homocysteine associated with incident dementia. J Neurol Neurosurg Psychiatry 2008;79:864-868.
16. Park JH, Kwon YC. Modification of the mini-mental state examination for use in the elderly in a non-western society: Part I. Development of Korean version of Mini-Mental State Examination. Int J Geriatr Psychiatry 1990;5:381-387.
17. Lawton MP, Brody EM. Assessment of older people: self-maintaining and instrumental activities of daily living. Gerontologist 1969;9:179-186.
18. Hughes CP, Berg L, Danziger WL, Coben LA, Martin RL. A new clinical scale for the staging of dementia. Br J Psychiatry 1982;140:566-572. (Pubitemid 12124384)
19. American Psychiatric Association. Diagnostic and statistical manual of mental disorder. 4th ed. Washington, DC: American Psychiatric Press; 1994.
20. McKhann G, Drachmen D, Folstein M, Katzman R, Price D, Stadlan EM. Clinical diagnosis of Alzheimer's disease: report of the NINCDS- ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's Disease. Neurology 1984; 34:939-944.
21. Roman GC, Tatemichi TK, Erkinjuntti T, Cummings JL, Masdeu JC, Garcia JH, et al. Vascular dementia: diagnostic criteria for research studies. Report of the NINDS-AIREN International Workshop. Neurology 1993;43:250-260.
22. Zivelin A, Rosenberg N, Peretz H, Amit Y, Kornbrot N, Seligsohn U. Improved method for genotyping apolipoprotein E polymorphins by a PCR-based assay simultaneously utilizing two distinct restriction enzymes. Clin Chem 1997;43:1657-1659.
23. Jung IK, Kwak DI, Joe SH, Lee HS. A study of standardization of Korean Form of Geriatric Depression Scale (KGDS). J Korean Geriatr Psychiatry 1997;1:61-72.
24. Yesavage JA, Brink TL, Rose TL, Lum O, Huang V, Adey M, et al. Development and validation of a geriatric depression scale: a preliminary report. J Psychiatr Res 1982-1983;17:37-49.
25. Beck AT, Ward CH, Mendelson M, Mock J, Erbaugh J. An inventory for measuring depression. Arch Gen Psychiatry 1961;4:561-571.
26. Zung WW. A self-rating depression scale. Arch Gen Psychiatry 1965; 12:63-70.
27. Hathaway SR, McKinley JC. The Minnesota Multiphasic Personality Inventory. Rev ed. Minneapolis, MN: University of Minnesota Press; 1943.
28. Radloff LS, Teri L. Use of the Center for Epidemiological Studies- depression scale with older adults. Clin Gerontol 1986;5:119-137.
29. Kim JM, Stewart R, Glozier N, Prince M, Kim SW, Yang SJ, et al. Physical health, depression and cognitive function as correlates of disability in an older Korean population. Int J Geriatr Psychiatry 2005;20:160-167.
30. Chen P, Ganguli M, Mulsant BH, DeKosky ST. The temporal relationship between depressive symptoms and dementia: a community-based prospective study. Arch Gen Psychiatry 1999;56:261-266.
31. Podewils LJ, Guallar E, Kuller LH, Fried LP, Lopez OL, Carlson M, et al. Physical activity, APOE genotype, and dementia risk: findings from the Cardiovascular Health Cognition Study. Am J Epidemiol 2005; 161:639-651.
32. Kim JM, Stewart R, Shin IS, Jung JS, Yoon JS. Assessment of association between mitochondrial aldehyde dehydrogenase polymorphism and Alzheimer's disease in an older Korean population. Neurobiol Aging 2004;25:295-301.
33. Brayne C, Harrington CR, Wischik CM, Huppert FA, Chi LY, Xuereb JH, et al. Apolipoprotein E genotype in the prediction of cognitive decline and dementia in a prospectively studied elderly population. Dementia 1996;7:169-174.
34. Lindsay J, Laurin D, Verreault R, Hébert R, Helliwell B, Hill GB, et al. Risk factors for Alzheimer's disease: a prospective analysis from the Canadian Study of Health and Aging. Am J Epidemiol 2002;156:445-453.
35. Andersen K, Lolk A, Kragh-Sørensen P, Petersen NE, Green A. Depression and the risk of Alzheimer disease. Epidemiology 2005;16: 233-238.
36. Devanand DP, Sano M, Tang MX, Taylor S, Gurland BJ, Wilder D, et al. Depressed mood and the incidence of Alzheimer's disease in the elderly living in the community. Arch Gen Psychiatry 1996;53:175-182.
37. Kim JM, Stewart R, Shin IS, Yoon JS. Vascular disease/risk and late- life depression in a Korean community population. Br J Psychiatry 2004;185:102-107.
38. Barnes DE, Alexopoulos GS, Lopez OL, Williamson JD, Yaffe K. Depressive symptoms, vascular disease, and mild cognitive impairment: findings from the Cardiovascular Health Study. Arch Gen Psychiatry 2006;63:273-279.
39. Borenstein Graves A, Mortimer JA, Bowen JD, McCormick WC, McCurry SM, Schellenberg GD, et al. Head circumference and incident Alzheimer's disease: modification by apolipoprotein E. Neurology 2001;57:1453-1460.
40. Haan MN, Shemanski L, Jagust WJ, Manolio TA, Kuller L. The role of APOE epsilon4 in modulating effects of other risk factors for cognitive decline in elderly persons. JAMA 1999;282:40-46.
41. Geda YE, Knopman DS, Mrazek DA, Jicha GA, Smith GE, Negash S, et al. Depression, apolipoprotein E genotype, and the incidence of mild cognitive impairment: a prospective cohort study. Arch Neurol 2006; 63:435-440.
42. Corsentino EA, Sawyer K, Sachs-Ericsson N, Blazer DG. Depressive symptoms moderate the influence of the apolipoproteine epsilon4 allele on cognitive decline in a sample of community dwelling older adults. Am J Geriatr Psychiatry 2009;17:155-165.
43. Krishnan V, Nestler EJ. The molecular neurobiology of depression. Nature 2008;455:894-902.
44. Bale TL. Stress sensitivity and the development of affective disorders. Horm Behav 2006;50:529-533.